Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Exxon Mobil Corporation (XOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Exxon Mobil Corporation — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Exxon Mobil Corporation trades at $167.62 (market cap $674.56B). The key difference: Exxon Mobil Corporation is far larger — about 394.5× Nuvation Bio Inc. Class A Common Stock's market cap, and Exxon Mobil Corporation pays a 2.51% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Exxon Mobil Corporation for 99 Days on average.
| NUVB | XOM | |
|---|---|---|
Market Cap | $1.71B | $674.56B |
Volume | 5,448,712 | 9,350,473 |
Sector | Health | Energy |
52-Week High | $9.54 | $171.52 |
52-Week Low | $3.41 | $110.64 |
Typical Hold Time | 0 Days | 99 Days |
Enterprise Value | $1.30B | $706.34B |
Dividend Yield | — | 2.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ExxonMobil (XOM) trades at $168.56, up 2.48% with strong technical momentum and bullish moving average signals. The company maintains solid profitability with 9.07% net margin and 12.55% ROE, though revenue declined to $323.91B in 2025. Recent news highlights potential Venezuela investment and Guyana/Permian expansion, while analyst consensus shows 36% buy ratings with $168.08 price target.
XOM presents a balanced opportunity with operational strength and strategic growth initiatives, though faces headwinds from declining revenue trends and geopolitical risks. The stock's current valuation at 21.11 P/E appears reasonable given cash flow generation, but investors should monitor execution on production targets and oil price volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Exxon Mobil Corporation
Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.
Read more on XOM →
